CR Pharma Said to Be Cleared for $2 Billion H.K. IPO Next Month

China Resources Pharmaceutical Group Ltd. received approval from the Hong Kong stock exchange for its proposed initial public offering, which may raise as much $2 billion next month in one of the world’s biggest IPOs this year, according to people with knowledge of the matter.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.